First Presentation of Parkinson Disease Patients to Neurologist

Boehringer Ingelheim logo

Boehringer Ingelheim

Status

Completed

Conditions

Parkinson Disease

Study type

Observational

Funder types

Industry

Identifiers

NCT00802178
248.613

Details and patient eligibility

About

In this study information is gathered about the treatment of Parkinson patients who present themselves in a neurological practice for the first time

Enrollment

2,448 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

- Parkinson Disease patients presenting to neurologist for first time

Exclusion criteria

- Hypersensitivity to the active substance or to any of the excipients

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems